TissGeneSummary for ARX |
Gene summary |
Basic gene information | Gene symbol | ARX |
Gene name | aristaless related homeobox | |
Synonyms | CT121|EIEE1|ISSX|MRX29|MRX32|MRX33|MRX36|MRX38|MRX43|MRX54|MRX76|MRX87|MRXS1|PRTS | |
Cytomap | UCSC genome browser: Xp21.3 | |
Type of gene | protein-coding | |
RefGenes | NM_139058.2, | |
Description | aristaless-related homeobox, X-linkedcancer/testis antigen 121homeobox protein ARX | |
Modification date | 20141207 | |
dbXrefs | MIM : 300382 | |
HGNC : HGNC | ||
Ensembl : ENSG00000004848 | ||
HPRD : 02307 | ||
Vega : OTTHUMG00000021275 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ARX | |
BioGPS: 170302 | ||
Pathway | NCI Pathway Interaction Database: ARX | |
KEGG: ARX | ||
REACTOME: ARX | ||
Pathway Commons: ARX | ||
Context | iHOP: ARX | |
ligand binding site mutation search in PubMed: ARX | ||
UCL Cancer Institute: ARX | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | OvaryPancreas | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | OVPAAD | |
Reference showing the relevant tissue of ARX | ||
Description by TissGene annotations | Have significant anti-correlated miRNA |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for ARX |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
COAD | -0.803853028 | 0.475196972 | -1.27905 | 0.00652 | 0.015100761 |
PRAD | 2.894081588 | 1.782629665 | 1.111451923 | 0.00334 | 0.009161493 |
LUSC | -0.651516753 | 0.470751874 | -1.122268627 | 0.00484 | 0.008128024 |
Top |
TissGene-miRNA for ARX |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
LUAD | hsa-miR-27a-3p | MIMAT0000084 | 0.038 | -0.27 | 60 |
UCS | hsa-miR-130a-3p | MIMAT0000425 | 0.033 | -0.29 | 56 |
LUAD | hsa-miR-139-5p | MIMAT0000250 | 0.021 | -0.3 | 60 |
LUAD | hsa-miR-27b-3p | MIMAT0000419 | 0.0042 | -0.37 | 60 |
Top |
TissGeneMut for ARX |
TissGeneSNV for ARX |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.E241Q | CESC | 1 |
p.E560D | UCEC | 1 |
p.V561L | LIHC | 1 |
p.G286A | GBM | 1 |
p.E320K | SKCM | 1 |
p.A302D | UCS | 1 |
p.S317R | LUAD | 1 |
p.E342K | SKCM | 1 |
p.Q48L | LIHC | 1 |
p.E360K | ESCA | 1 |
p.S26F | STAD | 1 |
p.G34R | COAD | 1 |
p.H298N | THCA | 1 |
p.R42W | STAD | 1 |
p.R35Q | SKCM | 1 |
p.E61K | SKCM | 1 |
p.R364W | BLCA | 1 |
p.P299S | TGCT | 1 |
p.L23F | LUAD | 1 |
p.C10S | LIHC | 1 |
p.R371P | HNSC | 1 |
p.L365M | READ | 1 |
p.L24R | COAD | 1 |
p.A534V | UCEC | 1 |
Top |
TissGeneCNV for ARX |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for ARX |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for ARX |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for ARX |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for ARX |
TissGeneDrug for ARX |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for ARX |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0025362 | Mental Retardation | 24 | BeFree |
umls:C0037769 | West Syndrome | 21 | BeFree,LHGDN,ORPHANET |
umls:C1136249 | Mental Retardation, X-Linked | 21 | BeFree,LHGDN |
umls:C0014544 | Epilepsy | 17 | BeFree |
umls:C3714756 | Intellectual Disability | 15 | BeFree,LHGDN |
umls:C1848199 | X-Linked Lissencephaly | 14 | BeFree |
umls:C2931919 | X-linked infantile spasm syndrome | 9 | BeFree |
umls:C0266463 | Lissencephaly | 8 | BeFree,LHGDN |
umls:C0027765 | nervous system disorder | 7 | BeFree |
umls:C0393706 | Early infantile epileptic encephalopathy with suppression bursts | 7 | BeFree,ORPHANET |
umls:C0013421 | Dystonia | 6 | BeFree,LHGDN |
umls:C0014550 | Epilepsies, Myoclonic | 5 | BeFree,LHGDN |
umls:C0175754 | Agenesis of corpus callosum | 5 | BeFree |
umls:C0266362 | Ambiguous Genitalia | 4 | BeFree |
umls:C0393593 | Dystonia Disorders | 4 | BeFree |
umls:C0424605 | Developmental delay (disorder) | 4 | BeFree |
umls:C0000768 | Congenital Abnormality | 3 | BeFree |
umls:C0036572 | Seizures | 3 | BeFree,LHGDN |
umls:C0220775 | RUSSELL-SILVER SYNDROME, X-LINKED | 3 | BeFree |
umls:C0543888 | Epileptic encephalopathy | 3 | BeFree |
umls:C0796250 | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 3 | BeFree,CLINVAR,CTD_human,ORPHANET |
umls:C0026650 | Movement Disorders | 2 | BeFree,LHGDN |
umls:C0036857 | Severe mental retardation (I.Q. 20-34) | 2 | BeFree |
umls:C0266449 | Congenital anomaly of brain | 2 | BeFree |
umls:C1096063 | Drug Resistant Epilepsy | 2 | BeFree |
umls:C1846171 | Lissencephaly, X-Linked, 2 | 2 | CLINVAR,CTD_human,MGD,ORPHANET,UNIPROT |
umls:C1848954 | Generalized dystonia | 2 | BeFree |
umls:C2931498 | Mental Retardation, X-Linked 1 | 2 | BeFree |
umls:C0004352 | Autistic Disorder | 1 | BeFree,GAD,LHGDN |
umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | RGD |
umls:C0011991 | Diarrhea | 1 | BeFree |
umls:C0020225 | Hydranencephaly | 1 | BeFree |
umls:C0020255 | Hydrocephalus | 1 | LHGDN |
umls:C0026106 | Mild Mental Retardation | 1 | BeFree |
umls:C0158687 | Congenital malformation of genital organs | 1 | BeFree |
umls:C0221760 | brain cyst | 1 | BeFree |
umls:C0234523 | Apraxia, Ideomotor | 1 | BeFree |
umls:C0235946 | Cerebral atrophy | 1 | BeFree |
umls:C0242350 | Erectile dysfunction | 1 | GAD |
umls:C0265219 | Miller Dieker syndrome | 1 | BeFree |
umls:C0270742 | Athetoid cerebral palsy | 1 | BeFree |
umls:C0393698 | Cryptogenic Infantile Spasms | 1 | BeFree |
umls:C0796124 | Proud Syndrome | 1 | CLINVAR,CTD_human,ORPHANET,UNIPROT |
umls:C0796244 | MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED (disorder) | 1 | CLINVAR,CTD_human,UNIPROT |
umls:C1510586 | Autism Spectrum Disorders | 1 | BeFree |
umls:C1837249 | Malformations of Cortical Development, Group II | 1 | BeFree |
umls:C3463992 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 1 | CLINVAR,CTD_human,MGD,ORPHANET,UNIPROT |